Keen Chung

Title: Keen Chung: Innovator in Molecular Guide Systems

Introduction

Keen Chung is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of molecular guidance systems, holding 2 patents that showcase his innovative work. His research focuses on the development of antibody conjugates that target intracellular processes involved in various diseases.

Latest Patents

Keen Chung's latest patents include a groundbreaking invention related to molecular guide system peptides. These patents disclose compositions that comprise an antibody conjugated to one or more molecular guidance system (MGS) peptides. The methods outlined in these patents involve treating subjects in need by administering an effective amount of the antibody conjugated to MGS peptides. This innovative approach targets intracellular targets involved in disease processes, offering potential new avenues for treatment.

Career Highlights

Keen Chung is currently associated with SRI International, where he continues to advance his research in molecular guidance systems. His work has the potential to impact various therapeutic areas, making him a valuable asset to the organization.

Collaborations

Keen Chung collaborates with talented individuals such as Kathlynn C Brown and Nathan Collins. Their combined expertise contributes to the innovative environment at SRI International.

Conclusion

Keen Chung's contributions to the field of molecular guide systems highlight his role as a leading inventor. His patents and ongoing research promise to enhance our understanding and treatment of complex diseases.